UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS)

Overview

UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS) presents recent evidence-based medical findings impacting cardiology practice from the past one to two years. This course covers a wide range of subspecialty topics including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention, and artificial intelligence.

On-demand cardiology education — accessible anytime, anywhere.

Agenda

This course provides recorded sessions originally delivered during the annual meeting, offering a comprehensive review of advances in heart disease. The agenda includes keynote lectures, clinical updates, and expert panel discussions.

• Welcome and Symposium Overview — Peter Ganz, MD
• Frontiers in Cardiology: Genetics, Artificial Intelligence and Deep Empathy (Chair: Priscilla Hsue, MD)
  • The Mind-Heart Connection: Stress and Trauma as Cardiovascular Risk Factors — Ahmed Tawakol, MD
  • Artificial Intelligence in Cardiology — Geoff Tison, MD, MPH
  • Ascending Thoracic Aortic Aneurysms: Evaluation, Management and Genetic Testing — Lisa Wilsbacher, MD, PhD
  • Update on Transthyretin Amyloidosis — Mandar Aras, MD, PhD
  • Gene Targeting for Cardiometabolic Diseases – Where are We? — John Chorba, MD
  • Elliot Rapaport Keynote Lecture: High Performance with Deep Empathy Medicine — Eric Topol, MD
• State-of-the-Art: Cardiovascular Interventions (Chair: Lucas Zier, MD, MS)
  • New Approaches to Pulmonary Embolism — Gregory Piazza, MD, MS
  • Physiological Assessment of Coronary Stenosis Severity by CT Angiography and in the Cath Lab — William Fearon, MD
  • Expanding Options in the Management of Endocarditis — Amy Fiedler, MD, MS and Ann Bolger, MD
  • Surgical Approaches to Advanced Heart Failure — Jason Smith, MD
  • Revascularization in Stable Coronary Disease: Sorting through the Evidence — Jeffrey Zimmet, MD, PhD
• Advances and Controversies in Electrophysiology (Chair: Nora Goldschlager, MD)
  • Defining Sudden Cardiac Death in 2022 — Zian Tseng, MD, MAS
  • ECG Findings Suggesting High Arrhythmic Risk — Melvin Scheinman, MD
  • Debate: AFib Ablation Should be First Line Therapy in Patients with Symptomatic AFib — Adam Lee, MD and Tommy Dewland, MD
  • Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis and Therapy — Edward Gerstenfeld, MD, MS
  • The Effect of Alcohol, Exercise and Lifestyle on Atrial Fibrillation — Gregory Marcus, MD, MAS
  • Interventions for Novel/Genetic Arrhythmias — Vasanth Vedantham, MD, PhD
  • Debate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart Failure — Byron Lee, MD, MS and Joshua Moss, MD, MS
• Managing Heart Failure (Chair: Jonathan Davis, MD, MPHS)
  • Cardiogenic Shock — Jaya Mallidi, MD
  • New Heart Failure Guidelines for HFrEF — Jonathan Davis, MD, MPHS
  • New Heart Failure Guidelines for HFpEF — Jonathan Davis, MD, MPHS
  • Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for HFrEF — Anusha McNamara, PharmD and Rose Pavlakos, PharmD
  • Remote Monitoring of Patients with Cardiovascular Diseases — Liviu Klein, MD, MS
• Managing Cardiovascular Risk (Chair: Binh An P. Phan, MD)
  • The Effect of Salt and Salt Substitutes Consumption on Clinical Outcomes in Hypertension and Heart Failure — Michael Crawford, MD
  • Managing Cardiovascular Risk in the Elderly — Carlin Long, MD
  • Current Cholesterol Guidelines: Controversies and Agreements — Peter Ganz, MD
  • Where Are We with Non-Statin Lipid Modifying Therapy? — Jorge Plutzky, MD
  • Management of Cardiovascular Risk and Chronic Kidney Disease Progression with Patients with Diabetes — Lisa Murphy, MD, PhD
  • Impact of Air Pollution on Cardiovascular Outcomes — Karol Watson, MD, PhD

Objectives

• Provide optimal management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, and thromboembolic disease
• Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
• Apply best practices for surgical revascularization or percutaneous intervention in coronary heart disease management
• Recognize risk stratification strategies for cardiovascular disease
• Optimize management of ascending thoracic aorta disease and pulmonary embolism
• Understand the role of cardiac surgery in managing endocarditis
• Recognize the genetic basis of cardiovascular diseases
• Emphasize the importance of deep empathy in patient interactions
• Appreciate variations in pathophysiology and treatment outcomes among racial and ethnic groups
• Enhance management of cardiac amyloidosis
• Understand the connection between psychological factors and cardiovascular health
• Recognize the impact of air pollution as a cardiovascular risk factor

Speakers

• Peter Ganz, MD
• Priscilla Hsue, MD
• Ahmed Tawakol, MD
• Geoff Tison, MD, MPH
• Lisa Wilsbacher, MD, PhD
• Mandar Aras, MD, PhD
• John Chorba, MD
• Eric Topol, MD
• Lucas Zier, MD, MS
• Gregory Piazza, MD, MS
• William Fearon, MD
• Amy Fiedler, MD, MS
• Ann Bolger, MD
• Jason Smith, MD
• Jeffrey Zimmet, MD, PhD
• Nora Goldschlager, MD
• Zian Tseng, MD, MAS
• Melvin Scheinman, MD
• Adam Lee, MD
• Tommy Dewland, MD
• Edward Gerstenfeld, MD, MS
• Gregory Marcus, MD, MAS
• Vasanth Vedantham, MD, PhD
• Byron Lee, MD, MS
• Joshua Moss, MD, MS
• Jonathan Davis, MD, MPHS
• Jaya Mallidi, MD
• Anusha McNamara, PharmD
• Rose Pavlakos, PharmD
• Liviu Klein, MD, MS
• Binh An P. Phan, MD
• Michael Crawford, MD
• Carlin Long, MD
• Jorge Plutzky, MD
• Lisa Murphy, MD, PhD
• Karol Watson, MD, PhD

This course content was originally presented at the 39th Annual Advances in Heart Disease conference, sponsored by UCSF. The program features expert faculty from leading academic institutions in North America, including University of California, San Francisco physicians and teachers.

Target Audience

This course is designed for cardiovascular specialists, practicing cardiologists, internists, family physicians, and other healthcare professionals involved in cardiovascular disease management.

Why This Topic Matters

UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS) addresses critical advancements in cardiology that influence clinical decisions and patient care. The comprehensive content covers diverse cardiovascular topics relevant to contemporary practice.

By providing access through MedHub Central, this course supports clinicians in strengthening their expertise and maintaining current knowledge within the cardiology specialty, reinforcing professional competence in a rapidly evolving field.